Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Systemic Sclerosis Topic Center

Exclusives

GLN logo
Podcast
Interstitial Lung Disease and Esophageal Disorders: When Specialties Work Together
01/23/2024
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...
In this special podcast Dr Rita...
01/23/2024
Rheumatology & Arthritis
News
Systemic Sclerosis and Interstitial Lung Disease: An Intertwined Revelation
03/21/2023
While screening patients with systemic sclerosis (SSc) for interstitial lung disease (ILD) is important, the reverse – screening patients with ILD for SSc – is equally critical.
While screening patients with systemic sclerosis (SSc) for interstitial lung disease (ILD) is important, the reverse – screening patients with ILD for SSc – is equally critical.
While screening patients with...
03/21/2023
Rheumatology & Arthritis
News
FDA Fast-Tracks Drug for SSc-ILD
09/16/2022
Earlier designated an orphan drug, efzofitimod has been fast-tracked for the treatment of systemic sclerosis-associated interstitial lung disease.
Earlier designated an orphan drug, efzofitimod has been fast-tracked for the treatment of systemic sclerosis-associated interstitial lung disease.
Earlier designated an orphan...
09/16/2022
Rheumatology & Arthritis
Elizabeth Volkmann
Podcast
Elizabeth Volkmann, MD, on COVID-19 Among Patients With Scleroderma
08/18/2022
In this podcast, Dr Elizabeth Volkmann from UCLA discusses her experience working with patients who have scleroderma and interstitial lung disease during the pandemic, including the impact of some drugs on vaccine response.
In this podcast, Dr Elizabeth Volkmann from UCLA discusses her experience working with patients who have scleroderma and interstitial lung disease during the pandemic, including the impact of some drugs on vaccine response.
In this podcast, Dr Elizabeth...
08/18/2022
Rheumatology & Arthritis
Poll: SSc and Fatigue
Poll
Poll: SSc and Fatigue
05/12/2021
What is the best way to treat fatigue in patients with systemic sclerosis? Tell us what you think with our quick poll!
What is the best way to treat fatigue in patients with systemic sclerosis? Tell us what you think with our quick poll!
What is the best way to treat...
05/12/2021
Rheumatology & Arthritis
Podcast
Interstitial Lung Disease and Esophageal Disorders: When Specialties Work Together
01/02/2002
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...
In this special podcast Dr Rita...
01/02/2002
Gastroenterology
From Gastroenterology

Q&As

Q&As
4 Questions About Predictors in Systemic Sclerosis-Interstitial Lung Disease
07/09/2019
Interstitial lung disease is the leading cause of mortality among patients with systemic sclerosis. There are no validated prediction tools for rheumatologists to use to determine which patients’ lung disease will progress....
Interstitial lung disease is the leading cause of mortality among patients with systemic sclerosis. There are no validated prediction tools for rheumatologists to use to determine which patients’ lung disease will progress....
Interstitial lung disease is...
07/09/2019
Rheumatology & Arthritis
Alexis Ogdie, MD
Q&As
Alexis Ogdie, MD, on Achieving Minimal Disease Activity Among Patients With PsA
10/04/2023
Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.
Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.
Dr Ogdie answers our questions...
10/04/2023
Rheumatology & Arthritis
Dr Ching-Lung Cheung
Q&A
Ching-Lung Cheung, PhD, on the Health Burden of Osteoporotic Fractures Among the Aging Population
09/29/2023
Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.
Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.
Dr Cheung agreed to answer a few...
09/29/2023
Rheumatology & Arthritis
Monica Schwartzman
Q&A
Monica Schwartzman, MD, on Medication Preferences Among Patients With PsA
08/21/2023
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our...
08/21/2023
Rheumatology & Arthritis
Lars Klareskog, MD
Q&A
Lars Klareskog, MD, on the Study of Occupational Exposures and Risk of RA
08/08/2023
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a...
08/08/2023
Rheumatology & Arthritis
Yassein Shamout, MD, FRCPC, DABD
Q&As
Optimizing Patient Care: Collaboration Between Dermatology and Rheumatology
06/20/2023
Jessica Garlewicz, Associate Digital Editor
A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.
A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.
A recent abstract published in...
06/20/2023
The Dermatologist
Jennifer L Barton, MD, MCR
Q&As
Jennifer L Barton, MD, on Goal Elicitation for Patients with RA
01/06/2023
In this Q&A, Dr. Barton discusses the development of a goal elicitation tool for patients with rheumatoid arthritis.
In this Q&A, Dr. Barton discusses the development of a goal elicitation tool for patients with rheumatoid arthritis.
In this Q&A, Dr. Barton...
01/06/2023
Rheumatology & Arthritis
Saundra Jain
Q&A
Wellness in Rheumatic Diseases: A Conversation with Saundra Jain, MS, PsyD, and Andrew Laster, MD
09/30/2022
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS,...
09/30/2022
Rheumatology & Arthritis
Dana Villmore
Q&A
Dana Villmore, PhD, Pa-C, on Treating Fibromyalgia in a Primary Care Setting
07/20/2022
In this Q&A, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers.
In this Q&A, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers.
In this Q&A, Dana Villmore, PhD,...
07/20/2022
Rheumatology & Arthritis
Betty Hsaio
Q&A
Betty Hsiao, MD, on Patient Conceptualization of RA Treatment
07/19/2022
Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.
Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.
Dr Betty Hsiao, from the Yale...
07/19/2022
Rheumatology & Arthritis
Alexis Ogdie
Q&A
Alexis Ogdie, MD, on a Treat To Target Approach to Psoriatic Arthritis
06/29/2022
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving...
06/29/2022
Rheumatology & Arthritis

Interactive

doctor writing on clipboard
Poll
Assessing Cardiac Risk in SSc
07/13/2021
How do you assess risk of cardiac axis deviation among patients with systemic sclerosis? Tell us with our quick poll!
How do you assess risk of cardiac axis deviation among patients with systemic sclerosis? Tell us with our quick poll!
How do you assess risk of...
07/13/2021
Rheumatology & Arthritis
Poll: SSc and Fatigue
Poll
Poll: SSc and Fatigue
05/12/2021
What is the best way to treat fatigue in patients with systemic sclerosis? Tell us what you think with our quick poll!
What is the best way to treat fatigue in patients with systemic sclerosis? Tell us what you think with our quick poll!
What is the best way to treat...
05/12/2021
Rheumatology & Arthritis
Quiz
QUIZ: Predictors in Systemic Sclerosis-Interstitial Lung Disease
05/29/2019
  A recent study found that during the first 2 years of treatment with immunosuppression, one of the most important predictors of long-term mortality in systemic sclerosis-interstitial lung disease...
  A recent study found that during the first 2 years of treatment with immunosuppression, one of the most important predictors of long-term mortality in systemic sclerosis-interstitial lung disease...
  A recent study...
05/29/2019
Rheumatology & Arthritis
Quiz
Acute Exacerbation in SSc-ILD
06/30/2011
Do you know which patients with systemic sclerosis-associated interstitial lung disease are at the highest risk of suffering acute exacerbation? Take our quiz to find out!
Do you know which patients with systemic sclerosis-associated interstitial lung disease are at the highest risk of suffering acute exacerbation? Take our quiz to find out!
Do you know which patients with...
06/30/2011
Rheumatology & Arthritis
Poll
Poll: Gout Among Older Adults
04/22/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
What has contributed to suboptimal serum urate monitoring among older adults with gout? Tell us what you think by taking our quick poll.
What has contributed to suboptimal serum urate monitoring among older adults with gout? Tell us what you think by taking our quick poll.
What has contributed to...
04/22/2024
Rheumatology & Arthritis
Quiz
Body Mass Index and the Risk of Rheumatic Diseases
03/14/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Is obesity a risk and severity factor among patients with rheumatic conditions? Or does weight have no bearing on autoimmune disorders? Find out with one quick question!
Is obesity a risk and severity factor among patients with rheumatic conditions? Or does weight have no bearing on autoimmune disorders? Find out with one quick question!
Is obesity a risk and severity...
03/14/2024
Rheumatology & Arthritis
Quiz
Quiz: Predictors of Psoriatic Arthritis
02/22/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
Researchers developed the...
02/22/2024
Rheumatology & Arthritis
Quiz
Quiz: Managing Gout Flare-ups
02/06/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Take a quick quiz to test your knowledge on gout, a form of arthritis typically characterized by severe pain, redness, and tenderness in joints.
Take a quick quiz to test your knowledge on gout, a form of arthritis typically characterized by severe pain, redness, and tenderness in joints.
Take a quick quiz to test your...
02/06/2024
Rheumatology & Arthritis
spinal xray
Quiz
Fracture Risks in Axial Spondyloarthritis
02/01/2024
A retrospective cohort study identified 1426 adults with prevalent ankylosing spondylitis. Do you know the characteristic with the highest odds ratio to fractures among these patients? Take our quiz to test your knowledge!
A retrospective cohort study identified 1426 adults with prevalent ankylosing spondylitis. Do you know the characteristic with the highest odds ratio to fractures among these patients? Take our quiz to test your knowledge!
A retrospective cohort study...
02/01/2024
Rheumatology & Arthritis
Quiz
Axial Spondyloarthritis and Age
01/12/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Patients in which age group are most commonly affected by axial spondyloarthritis? Take our quiz to test your knowledge!
Patients in which age group are most commonly affected by axial spondyloarthritis? Take our quiz to test your knowledge!
Patients in which age group are...
01/12/2024
Autoimmune
Quiz
Quiz: Fractures Among Patients With Ankylosing Spondylitis
12/30/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Researchers found some key factors responsible for higher odds of fracture among older patients with ankylosing spondylitis. Take our quiz to test your knowledge!
Researchers found some key factors responsible for higher odds of fracture among older patients with ankylosing spondylitis. Take our quiz to test your knowledge!
Researchers found some key...
12/30/2023
Autoimmune
Quiz
Quiz: Mortality Among Patients With AS and nr-axSpA
12/29/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Researchers found differences in life expectancy among patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis. Take our quiz to test your knowledge on the subject!
Researchers found differences in life expectancy among patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis. Take our quiz to test your knowledge on the subject!
Researchers found differences in...
12/29/2023
Rheumatology & Arthritis
Quiz
Treatment for Nonrad axSpA
12/04/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
What do current professional guidelines advise for first-line treatment of axial diseases? Test your knowledge with this quick quiz!
What do current professional guidelines advise for first-line treatment of axial diseases? Test your knowledge with this quick quiz!
What do current professional...
12/04/2023
Rheumatology & Arthritis
Giant Cell Arteritis
Quiz
Giant Cell Arteritis
11/19/2023
Test your knowledge of giant cell arteritis by taking this short quiz based on facts from the American College of Rheumatology.
Test your knowledge of giant cell arteritis by taking this short quiz based on facts from the American College of Rheumatology.
Test your knowledge of giant...
11/19/2023
Rheumatology & Arthritis

Podcasts

GLN logo
Podcast
Interstitial Lung Disease and Esophageal Disorders: When Specialties Work Together
01/23/2024
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...
In this special podcast Dr Rita...
01/23/2024
Rheumatology & Arthritis
Elizabeth Volkmann
Podcast
Elizabeth Volkmann, MD, on COVID-19 Among Patients With Scleroderma
08/18/2022
In this podcast, Dr Elizabeth Volkmann from UCLA discusses her experience working with patients who have scleroderma and interstitial lung disease during the pandemic, including the impact of some drugs on vaccine response.
In this podcast, Dr Elizabeth Volkmann from UCLA discusses her experience working with patients who have scleroderma and interstitial lung disease during the pandemic, including the impact of some drugs on vaccine response.
In this podcast, Dr Elizabeth...
08/18/2022
Rheumatology & Arthritis
doc & patient
Podcasts
Kristin Highland, MD, on Diagnosis and Management of Systemic Sclerosis
07/30/2021
Dr Highland, from the Cleveland Clinic, provides an overview of systemic sclerosis and associated interstitial lung disease, including symptoms and diagnosis, who's at risk, and new and upcoming treatments for this complex disease.
Dr Highland, from the Cleveland Clinic, provides an overview of systemic sclerosis and associated interstitial lung disease, including symptoms and diagnosis, who's at risk, and new and upcoming treatments for this complex disease.
Dr Highland, from the Cleveland...
07/30/2021
Rheumatology & Arthritis
Volkmann
Podcast
Elizabeth Volkmann, MD, on Treating and Monitoring Patients With SSc-ILD
07/21/2021
In this podcast, Dr Volkmann, director of the UCLA Scleroderma Program and the founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) Program, discusses treatment and monitoring of patients...
In this podcast, Dr Volkmann, director of the UCLA Scleroderma Program and the founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) Program, discusses treatment and monitoring of patients...
In this podcast, Dr Volkmann,...
07/21/2021
Rheumatology & Arthritis
Volkmann
Podcasts
Elizabeth Volkmann, MD, on the Gut Microbiome in Systemic Sclerosis
05/13/2021
In this podcast, Elizabeth Volkmann, MD, discusses her research into how the gut microbiome of patients with systemic sclerosis may be associated with the pathogenesis of the disease, how environmental influences may affect gut dysbiosis, and...
In this podcast, Elizabeth Volkmann, MD, discusses her research into how the gut microbiome of patients with systemic sclerosis may be associated with the pathogenesis of the disease, how environmental influences may affect gut dysbiosis, and...
In this podcast, Elizabeth...
05/13/2021
Rheumatology & Arthritis
Vikas Majithia
Podcast
Vikas Majithia, MD, and Ronald Butendieck, MD, on the Continuing Challenges of Gout
06/20/2024
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck...
06/20/2024
Rheumatology & Arthritis
Podcast
Drs Bryant England and Ben Smith on Integrative Care for Rheumatoid Arthritis
04/08/2024
In this podcast, Drs England and Smith discuss the key recommendations and how to implement exercise, rehabilitation, diet, and additional interventions as part of an integrative management approach for people with rheumatoid arthritis.
In this podcast, Drs England and Smith discuss the key recommendations and how to implement exercise, rehabilitation, diet, and additional interventions as part of an integrative management approach for people with rheumatoid arthritis.
In this podcast, Drs England and...
04/08/2024
Rheumatology & Arthritis
Dr Shari Lipner
Podcast
Could Isolated Nail Psoriasis Predict Psoriatic Arthritis?
03/27/2024

featuring Shari Lipner, MD, PhD

featuring Shari Lipner, MD, PhD ...
In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr...
In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr...
In a cross-sectional study of 36...
03/27/2024
Rheumatology & Arthritis
Jeff Sparks
Podcast
Risk Factors for Repeat COVID-19 Among Patients With Rheumatic Diseases
03/14/2024
Dr Jeffrey Sparks and research assistant Emily Kowalski from Brigham & Women's Hospital in Boston share their findings from a study of the risk factors found among patient with systemic rheumatic diseases for repeat infections with COVID-19.
Dr Jeffrey Sparks and research assistant Emily Kowalski from Brigham & Women's Hospital in Boston share their findings from a study of the risk factors found among patient with systemic rheumatic diseases for repeat infections with COVID-19.
Dr Jeffrey Sparks and research...
03/14/2024
Rheumatology & Arthritis
Neal Birnbam
Podcast
Neal Birnbaum, MD, on CMS Prior Authorization Rule Update
03/08/2024
Dr Birnbaum comments on how the new rule from the Centers for Medicare & Medicaid Services setting tighter timelines for health insurers to act on requests for authorization for medications and procedures.
Dr Birnbaum comments on how the new rule from the Centers for Medicare & Medicaid Services setting tighter timelines for health insurers to act on requests for authorization for medications and procedures.
Dr Birnbaum comments on how the...
03/08/2024
Rheumatology & Arthritis
Len Calabrese
Podcast
Leonard Calabrese, DO, on the Nosology of Long COVID
02/29/2024
Dr Leonard Calabrese of the Cleveland Clinic discusses the similarities and differences of fibromyalgia, chronic fatigue syndrome, and long COVID, and why classifying these diseases properly is important to diagnosis and treatment.
Dr Leonard Calabrese of the Cleveland Clinic discusses the similarities and differences of fibromyalgia, chronic fatigue syndrome, and long COVID, and why classifying these diseases properly is important to diagnosis and treatment.
Dr Leonard Calabrese of the...
02/29/2024
Rheumatology & Arthritis
GLN logo
Podcast
Interstitial Lung Disease and Esophageal Disorders: When Specialties Work Together
01/23/2024
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...
In this special podcast Dr Rita...
01/23/2024
Rheumatology & Arthritis
Dr Patricia Katz
Podcast
SARS‐CoV‐2 Vaccination Among Immunocompromised Patients Helps Mental Health
01/22/2024

featuring Patricia Katz, PhD

featuring Patricia Katz, PhD
Dr Patricia Katz sheds light on the cohort analysis findings that suggest a positive correlation between mental wellbeing—a common burden among patients with chronic inflammatory diseases—and COVID-19 vaccination.
Dr Patricia Katz sheds light on the cohort analysis findings that suggest a positive correlation between mental wellbeing—a common burden among patients with chronic inflammatory diseases—and COVID-19 vaccination.
Dr Patricia Katz sheds light on...
01/22/2024
Rheumatology & Arthritis
Matthew Baker
Podcast
Matthew Baker, MD, on the Association of Osteoarthritis With Atopic Dermatitis
01/19/2024
Dr Baker discusses research indicating that patients with asthma or atopic dermatitis have a significantly higher risk of developing osteoarthritis over 10 years of follow-up.
Dr Baker discusses research indicating that patients with asthma or atopic dermatitis have a significantly higher risk of developing osteoarthritis over 10 years of follow-up.
Dr Baker discusses research...
01/19/2024
Rheumatology & Arthritis
Tate Johnson, MD
Podcast
Tate Johnson, MD, on Aortic Stenosis and Rheumatoid Arthritis
01/11/2024

featuring Tate Johnson, MD

featuring Tate Johnson, MD
The risk of cardiovascular diseases among patients with rheumatoid arthritis goes beyond just heart attacks and strokes. Findings of a large cohort study revealed that patients with RA were at a higher risk of developing aortic stenosis—which...
The risk of cardiovascular diseases among patients with rheumatoid arthritis goes beyond just heart attacks and strokes. Findings of a large cohort study revealed that patients with RA were at a higher risk of developing aortic stenosis—which...
The risk of cardiovascular...
01/11/2024
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay in the Know

Rheumatology & Arthritis Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Sponsored Video
The RheuMuseum Lecture Series: A Deeper Understanding of the Pathogenesis of axSpA
07/03/2024
Professor Iain McInnes of the University of Glasgow delves into the latest science on the importance of the interleukin-12 interleukin-17 axis in axial spondyloarthritis.
Professor Iain McInnes of the University of Glasgow delves into the latest science on the importance of the interleukin-12 interleukin-17 axis in axial spondyloarthritis.
Professor Iain McInnes of the...
07/03/2024
Rheumatology & Arthritis
Conference Coverage
Joshua Baker, MD, on Response to RA Treatment Based on BMI and Adiposity
11/12/2023
Dr Baker reviews research he and colleagues conducted into responses to different therapeutic strategies for rheumatoid arthritis according to patients' body mass index and adiposity.
Dr Baker reviews research he and colleagues conducted into responses to different therapeutic strategies for rheumatoid arthritis according to patients' body mass index and adiposity.
Dr Baker reviews research he and...
11/12/2023
Rheumatology & Arthritis
Sponsored Video
The RheuMuseum Lecture Series: The Pathogenesis of Psoriatic Arthritis
06/04/2024
The RheuMuseum Lecture Series continues with Professor Iain McInnes taking a deeper dive into the pathogenesis of psoriatic arthritis.
The RheuMuseum Lecture Series continues with Professor Iain McInnes taking a deeper dive into the pathogenesis of psoriatic arthritis.
The RheuMuseum Lecture Series...
06/04/2024
Rheumatology & Arthritis
News
Patients With nr-axSpA and r-axSpA Show Differences in Several Key Criteria
06/24/2024
Researchers found distinct variations between patients with nonradiographic and radiographic axial spondyloarthritis in age of disease onset, sex, and other factors.
Researchers found distinct variations between patients with nonradiographic and radiographic axial spondyloarthritis in age of disease onset, sex, and other factors.
Researchers found distinct...
06/24/2024
Rheumatology & Arthritis
News
PsA Patients Benefit from bDMARDS Regardless of Affected Joint Count
06/17/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
A first biologic disease-modifying antirheumatic drug showed similar efficacy among psoriatic arthritis patients with a low number of affected joints as among those with a high number.
A first biologic disease-modifying antirheumatic drug showed similar efficacy among psoriatic arthritis patients with a low number of affected joints as among those with a high number.
A first biologic...
06/17/2024
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement